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Abstract:  A  flow  injection  chemiluminescence  immunoassay  for  rapid  and  sensitive 
detection  of  carcinoembryonic  antigen  (CEA)  by  using  a  phenylboronic  acid-based 
immunoaffinity column as a glycoprotein collector was proposed in this paper. The column 
was  prepared  by  coupling  of  3-aminophenylboronic  acid  on  the  glass  beads  through  
a  γ-glycidoxypropyltrimethoxysilane  (GPMS)  linkage.  Based  on  an  indirect  competitive 
immunoreaction,  the  mixture  of  CEA  sample  and  enzyme  conjugated  CEA  antibody  
(HRP-anti-CEA) was incubated in advance, followed by direct injection to the column to 
capture free HRP-labeled CEA antibody in the column. The trapped HRP-labeled antibody 
was detected by flow inject chemiluminescence in the presence of luminol and hydrogen 
peroxide. The decreased chemiluminescent signal was proportional to the concentration of 
CEA in the range of 3.0–30.0 ng/mL with a correlation coefficient of 0.998. The column 
showed  an  acceptable  reproducibility  and  stability  and  is  potentially  used  for  practical 
clinical detection of the serum CEA level.  
Keywords:  flow  injection  chemiluminescence  immunoassay;  carcinoembryonic  antigen; 
boronic immunoaffinity column  
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1. Introduction 
 
Carcinoembryonic antigen (CEA) is a highly glycosylated cell surface glycoprotein with a total of 28 
asparagine-linked glycosylation sites [1]. It has been used  as an important tumor marker in disease 
diagnosis  for  colorectal,  pancreatic,  gastric,  and  cervical  carcinomas  [2].  Presently,  enzyme-linked 
immunoassays [3-4], fluorescence measurement [5-7] and chemiluminescence assay [8] are frequently 
used  to  detect  to  successfully  detect  the  CEA  in  practical  samples  with  high  selectivity,  sufficient 
sensitivity  and  precision.  However,  these  conventional  immunoassay  methods  need  enzyme  or 
fluorescent-labeled  antibody/antigen,  not  to  mention  its  lengthy  analysis  that  requires  highly  skilled 
personnel,  specially  equipped  laboratories,  and  expensive  chemicals  [9-11].  Therefore,  it  is  highly 
desirable for disease diagnosis to develop new methods for fast and convenient monitoring of CEA.  
Herein  we  adopted  a  boronic  immunoaffinity  column  as  glycoprotein  antibody  collector  in 
combination with flow injection immunoassay to develop a novel detection method for CEA. Alkyl or 
aryl boronic acids can react with vicinal diols to form boronate complexes [12]. The boronate groups 
could be immobilized on solid surface or in gel for recognition and separation of glycoproteins [13]. In 
this work, 3-aminophenylboronic acid was coupled on the glass microbead surface for construction of a 
boronic  immunoaffinity  column.  The  immobilized  APBA  on  glass  microbeads  was  prepared  for 
accumulation of glycoprotein antigen CEA, followed by the recognition of free horseradish peroxidase 
(HRP)-labeled CEA antibody in the mixture of the analyte CEA and HRP-labeled CEA antibody after 
incubation. The trapped HRP-labeled CEA antibody enhanced the chemiluminescence emission intensity 
of luminal system, which is the basic for detection of the analyte CEA in samples. 
 
2. Results and Discussion 
 
2.1. Binding performances of the immunoaffinity column 
 
The  3-aminophenylboronic  acid  (APBA)  coated  glass  microbeads  were  prepared  by  using  
γ-glycidoxypropyltrimethoxysilane  (GPMS)  as  linkage.  Then  the  as-prepared  APBA  modified 
microbeads were filled into a glassy tube followed by injection of a 250 ng/mL CEA solution into the 
column to form the immunoaffinity column. After that the column was connected to a spiral glass tube 
for  the  chemiluminescence  measurements.  The  preparation  of  the  immunoaffinity  column  and  the 
detection process were shown in Scheme 1. The binding performances of CEA to the APBA modified 
glass  microbeads  were  characterized  by  chemiluminescence  and  photometric  activity  measurements. 
Previous  studies  show  that  the  chemiluminescence  intensity  of  the  luminal  +  H2O2  system  can  be 
enhanced  by  HRP-labeled  antibody  [14].  It  is  the  basis  of  the  immunosensors  designed  here  that  
HRP-labeled antibodies is used as a CEA tracer for quantification of proteins. The mechanism for this 
emission  enhancement  through  HRP  was  illustrated  in  Scheme  2.  After  being  incubated  in  90  L  
HRP-anti-CEA and 10 L CEA at 37 ° C for 25 min, the mixture was injected to the column, which has 
been washed with PBS to establish the baseline before. Upon injection of luminal + p-iodophenol (PIP) 
+ H2O2 to the column, the chemiluminescence emission intensity detected behind the column (5 cm) was 
about 2.5 times higher than that of the column not exposed to HRP-labeled antibodies (Figure 1). The Sensors 2009, 9                                       
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enhanced emission indicated that there was the successful trapping of HRP-labeled antibodies by the 
immobilized antigen, which sensitized the reaction of luminol and hydrogen peroxide. 
Scheme 1. Schematic diagram of flow injection immunoassay system: (P) peristaltic pump, 
(V)  eight-way  valve,  (C)  immunoaffinity  column,  (PMT)  photo-multiplier,  (D) detector, 
(PC) computer. 
 
 
In the control experiments using bovine serum albumin (BSA), HRP, instead of HRP-labeled CEA 
antibody to inject into the bioreactor, no enhanced CL intensity can be observed (Figure 1). The HRP is 
known as a glycoprotein with degree of glycosylation of 16–21% [15]. Therefore, it is possible that 
there are two binding modes reacting with the APBA interface directly and/or replace CEA on the 
APBA-modified  surface,  consequently  resulting  in  a  nonspecific  increase  of  the  chemiluminescence 
emission intensity. Indeed, when injection of free HRP into the column filled with APBA-modified glass 
beads without CEA, an increase of the chemiluminescence emission intensity was observed (data not 
shown). After blocking the APBA-modified glass beads with CEA, however, injection of free HRP did 
not exhibited clearly enhancement of the chemiluminescent emission intensity (Figure 1). This result 
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showed a much weak-binding interaction between HRP and APBA after saturating the APBA interface 
with CEA. Thus, the increase of the emission intensity in the previous experiment is attributed to the 
presence of HRP-labeled antibody on the CEA-modified surface, which quantitatively correlates to the 
amount of free CEA in the sample. 
Scheme 2. The mechanism for the CL emission enhancement through HRP. 
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Figure  1.  Control  experiments  by  flow  of  100  L  of  0  ng/mL  CEA  without  
enzyme-labeled, 0.1 mg/mL BSA, 2 mg/mL HRP and 9:1 of HRP-labeled anti-CEA and 
CEA  standard  solution  containing  0  ng/mL  after  being  incubated  at  room  temperature  
for 25 min. The substrate solution is 0.5 mM luminol + 4 mM H2O2 + 0.4 mM PIP. 
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The  specific  formation  of  immunocomplex  of  HRP -labeled  CEA  antibody  and  CEA  w as  further 
demonstrated  by  photometric  activity  measurements  using  tetramethyl  benzidine  (TMB)  as   
substrate [12]. After reacting with HRP labeled anti-CEA, the glass beads were added to  TMB  solution 
containing H 2O2, there is a large absorbance observed at 654 nm. Adding the CEA modified glass beads Sensors 2009, 9                                       
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to the above detection solution without incubation, no clear absorbance at 654 nm was observed. This 
illustrated  that  the  immobilized  CEA  on  the  glass  beads  could  bind  with  HRP-labeled  anti-CEA 
thorough immunoreaction and blocked free HRP close to the APBA interface. 
 
2.2. Non-competitive immunoassays for CEA detection 
 
The determination of CEA was based on the non-competitive immunoassay. A phosphate buffer 
solution (PBS, 0.1 M, pH 7.0) was used as the carrier. Ninety L of HRP-labeled anti-CEA and 10 L 
of  CEA  standard  solution  were  mixed  and  loaded  on  the  immunoaffinity  column  at  a  flow  rate  
of 0.05 mL/min, followed washing with PBST (pH 7.0, containing 0.05% Triton X-100) to remove the 
unreacted HRP-labeled anti-AFP and physically adsorbed enzyme. Then luminol, PIP and H2O2 were 
mixed and delivered to the column with the aid of the valve; the CL signal was detected. To optimize 
the pre-incubation time, 10 µL 0 ng/mL CEA was incubated with 90 µL HRP-labeled antibody at 37 º C, 
detected at different time intervals, as shown in Figure 2. At the pre-incubation time of 25 min, the CL 
intensity decreased to a minimum value, indicating a maximum combination of CEA with its enzyme 
tracer. Thus, a pre-incubation of 25 min was chosen for the present system.  
Figure 2. Effect of the pre-incubation time on CL intensity of 0 ng/mL CEA 1:9 mixed with 
enzyme tracer. 
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Figure  3 shows the effect of the flow rate on the CL intensity. The relative low flow rate is in favor 
of trapping free enzyme tracer in column. The result showed that the lowest flow rate from our pump 
was 0.05 mL/min, which was selected as the flow rate of the immunomixture.  Sensors 2009, 9                                       
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Figure 3. Effect of flow rate of pre-incubation immunomixture through the immunoaffinity 
column  on  the  CL  intensity.  Pre-incubation  time  of  0  ng/mL  CEA  with  enzyme  tracer  
was 25 min  
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The  CL  intensity  was  decreased  with  the  increasing  CEA  concentration  as  shown  in  Figure  4, 
showing  a  li near  range  of  3 –30 ng/mL with a correlation coeffience of 0.998 (insert in Figure 4). The 
regression equation was I = 284.38 – 8.97c (ng/mL), where I is the relative CL intensity and c is the 
CEA  concentration.  When  the  CEA  concentration  was  increased  up  to  30  ng/mL,  an  appropriate 
dilution of sample was needed in the pre-incubation step. 
Figure  4.  Dose-response  curve  for  CEA.  Inset:  Plots  of  CL  intensity  versus  CEA 
concentration in pre-incubation solution. 
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Regeneration properties of the column are very important to a flow-injection immunoassay system. 
Due  to  the  low  binding  stability  of  glycoprotein  and  boronic  acid  in  acidic  solutions,  the  alkaline 
solution of 10 mM NaOH, was used in the present system to disrupt the antigen-antibody complex. The 
column  was  flowed  by  10  mM  NaOH  solutions  for  1 min, and then equilibrated with 0.1 M PBS  
(pH 7.0) for 1 min. The chemiluminescence emission intensity was decreased to its back value due to 
the  release  of  the  bound HRP-labeled CEA antibody. After reinjection of enzyme conjugated CEA 
antibody  to  the  column  followed  by  injection  of  luminal  +  PIP  +  H2O2  to  the  reactor,  the 
chemiluminescence emission intensity was increased to the value before regeneration, indicating the 
rebinding  of  enzyme  conjugated  CEA  antibody  with  CEA  on  the  support  surface.  At  one 
immunoaffinity column, the mean steady-state CL intensity was 510 with a relative standard deviation 
of 1.95% for twelve determinations at 0 ng/mL of CEA in the pre-incubation solution with 0.5 mM 
luminol + 4 mM H2O2 + 0.4 mM PIP as substrates as shown in Figure 5. When the immunoassay 
column  was  not  in  use,  it  was  stored  in  PBS  (pH  7.0)  at  4  º C.  No  obvious  change  was  found  
after  15  days.  The  fabrication  reproducibility  of  three  column,  made  independently,  exhibited  an 
acceptable reproducibility with a relative standard deviation of 1.81% for the CL intensity determined  
at 3 ng/mL of CEA in the pre-incubation solution with 0.5 mM luminol + 4 mM H2O2 + 0.4 mM PIP as 
substrates (Figure 6). This indicated that the immunoassay column possess good reproducibility and 
could  be  used  repeatedly.  The  whole  assay  process  including  regeneration  of  the  reactor  could  be 
achieved  in  31  min.  The  total  analytical  time  was  shorter  than  that  of  40  min  with  amperometric 
immunosensor  [16],  more  than  1  h  with  the  conventional  immunoassay  methods,  including 
radioimmunoassay,  single  radial  immunodiffusion,  immuno-turbidimetry  and  enzyme-linked 
immunoassay [17,18].  
Figure  5. The CL intensity of 0.5 mM luminol + 4 mM H2O2 + 0.4 mM PIP at CEA 
concentration of 0 ng/mL after regeneration of the immunoaffinity reactor by 10 mM NaOH. 
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Figure 6. Reproducibility of the immunoaffinity reactor, 0.5 mM luminol + 4 mM H2O2  
+ 0.4 mM PIP at CEA concentration of 3 ng/mL. 
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The  serum  CEA  levels  in  five  samples  were  detected  using  the  proposed  flow  injection 
chemiluminescence immunoassay. The CEA concentrations in the clinical serum of some patients were 
beyond the linear range of the described method; thus proper dilution with 0.85% NaCl before assay 
was  necessary.  The  average  concentrations  of  the  serum  CEA  samples  were  determined  
to  be  31.9,  83.3,  3.7,  5.9  and  223.6  ng  mL
-1,  respectively.  The  results  are  compared  with  those  
of  29.6,  81.9,  3.8,  5.2  and  200.5  ng  mL
-1  obtained  using  a  standard  method  provided  by  Jiangsu 
Institute  of  Cancer  Prevention  and  Cure,  respectively.  The  relative  deviations  are  in  the  range  
from 7.2 to 12.1% between the two methods, which was considered as acceptable.  
 
3. Materials and Methods 
 
Carcinoembryonic antigen and horseradish peroxidase (HRP)-labeled CEA antibody (HRP-anti-CEA) 
were purchased from CanAg Diagnostics AB. Bovine serum albumin (BSA), horseradish peroxidase,  
3-aminophenylboronic acid were obtained from Sigma-aldrich Chemical Company (Shanghai, China).  
γ-Glycidoxypropyltrimethoxysilane was provided by Jintan Huadong Coupling Agent Co., Ltd. (Jiangsu, 
China). Glass microbeads (80-mesh) were purchased from Shanghai Chemical Plant (Shanghai, China). 
p-Iodophenol was purchased from Weihai Newera Chemical Co. Ltd. (Shandong, China). All other 
chemicals were of analytical grade and used without further purification. Deionized water was used 
throughout the study. A stock solution of 0.01 M luminol was prepared by dissolving 177 mg of luminol 
in 100 mL of 1 M NaOH and was stored in dark. The stock solution of 0.01 M PIP was made by 
dissolving 220 mg PIP in 10 mL of dimethylsulfoxide (DMSO) and then diluted with water to 100 mL, 
followed by storage in dark. Prior to the use, both luminol and PIP solutions were diluted with 0.1 M 
Tris-HCl buffer solution (pH 8.5) to the desired concentrations. Sensors 2009, 9                                       
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Five grams of glass microbeads were boiled in 5% HNO3 for 1 h. After washing thoroughly with 
water and drying at 130 º C for 4 h, the activated glass beads were reacted with 100 mL of 5% GPMS in 
dry toluene at room temperature under stirring overnight. Then they were washed with toluene and 
ethanol and dried under a nitrogen atmosphere at 100 º C for 1 h. After that the beads were soaked  
in 6 mL 10 mg/mL APBA solution under stirring at 4 º C for 24 h. The column was fabricated by filling 
the APBA modified microbeads into a glassy tube (1.6 mm inner diameter and 5 cm length). For CEA 
immobilization, 300 L 250 ng/mL CEA solution was injected to the column and incubated for 1 h  
at 4 º C. The CEA immobilized column was then connected to a spiral glass tube (2.0 mm inner diameter 
and 10 cm length) for the follow experiments.  
The  determination  of  CEA  was  based  on  a  non-competitive  immunoassay.  A  phosphate  buffer 
solution (PBS, 0.1 M, pH 7.0) was used as the carrier. 90 L HRP-labeled anti-CEA and 10 L CEA 
standard solution were mixed and incubated at 37 ºC  for 25 min. After a stable baseline was recorded, 
the mixture was loaded on the immunoaffinity column at a flow rate of 0.05 mL/min. The column was 
washed with PBST (pH 7.0, containing 0.05% Triton X-100) for 1 min at a rate of 1.0 mL/min to 
remove the unreacted HRP-labeled anti-AFP and physically adsorbed enzyme. Then luminol, PIP and 
H2O2 were mixed and delivered to the column with the aid of the valve; the CL signal was detected with 
IFFM-E Luminescence Analyzer (Remax, China). The modified glass beads were regenerated with a 
flow  of  10  mM  NaOH  for  1  min,  and  then  equilibrated  with  0.1  M  pH  7.0  PBST  
for  1  min.  The  total  assay  time  was  31 min, including 25 min of pre-incubation and 6 min of the  
detection and regeneration. 
 
4. Conclusions 
 
In  summary,  we  developed  a  rapid  and  sensitive  immunoassay  based  on  a  phenylboronic  acid 
immunoaffinity column in combination with a flow injection chemiluminescence (CL) for determination 
of glycated antigen protein. With the sugar-boronic interaction, the CEA could be easily immobilized on 
APBA coated glass beads. After an off-line incubation, the free HRP-labeled antibody in the mixture of 
the  analyte  CEA  with  HRP-labeled  AFP  antibody  was  captured  by  the  immobilized  antigen  in  the 
column.  The  trapped  HRP-labeled  antibody  on  column  enhanced  the  chemiluminescence  emission 
intensity  of  the  reaction  of  luminol  and  hydrogen  peroxide,  which  quantitatively  correlates  to  the 
amount of free CEA in the sample. The whole assay process including regeneration of the reactor could 
be achieved in 31 min. The described method was shown as a acceptable detection with fabrication 
reproducibility. It is proven to be fast and simple and could be further developed for practical clinical 
detection of serum CEA levels.  
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